CompletedNCT01189006
Dextromethorphan Added to Risperidone for Schizophrenia
About this title
Read the official source —This study evaluated the effectiveness of Dextromethorphan for people with schizophrenia.
Medication studyAges 18–65Taiwan
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of Dextromethorphan for people with schizophrenia.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- TainanSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateJanuary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 161
- Sponsor
- National Cheng-Kung University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Taiwan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01189006
- Official title
Show the full official title
A Double-blind, Placebo-Controlled, Randomized Study of the Efficacy of Dextromethorphan as Add-On Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
Get this study by email
Recruitment & locations
CompletedTainan
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of Dextromethorphan for people with schizophrenia.
Who is behind this study?
The study sponsor is National Cheng-Kung University Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Dextromethorphan.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
